A NEW RECOMBINANT ADENO-ASSOCIATED VIRUS (AAV)-BASED RANDOM PEPTIDE DISPLAY LIBRARY SYSTEM: INFECTION-DEFECTIVE AAV1.9-3 AS A NOVEL DETARGETED PLATFORM FOR VECTOR EVOLUTION
Open Access
- 1 October 2010
- journal article
- research article
- Published by World Scientific Pub Co Pte Ltd in Gene Therapy and Regulation
- Vol. 05 (01) , 31-55
Abstract
Directed evolution through genetic engineering of viral capsids followed by selection has emerged as a powerful means to create novel recombinant adeno-associated virus (rAAV) vectors with desired tropism and enhanced properties. One of the most effective approaches uses rAAV-based random peptide display libraries. Here we report a novel system based on an infection-defective rAAV1.9-3 as a platform for random peptide display, and show that biopanning of the libraries in vitro effectively identifies the peptides that restore and enhance rAAV transduction. rAAV1.9-3 has a genetically engineered AAV1 capsid with amino acids 445–568 being replaced with those of AAV9, and has been identified as a variant exhibiting significantly impaired infectivity and delayed blood clearance when infused into mice. In this study, we generated rAAV1.9-3 variant libraries in which 7- or 12-mer random peptides were expressed at the capsid amino acid position 590. Three rounds of positive selection for primary human dermal fibroblasts successfully identified new rAAV-peptide variants that transduce them more efficiently than the prototype rAAV2. Thus our study demonstrates that an infection-defective rAAV variant serves as a novel detargeted platform for random peptide display libraries. We also describe a brief review of recent progress in rAAV-based random peptide display library approaches.Keywords
This publication has 64 references indexed in Scilit:
- Molecular Evolution of Adeno-associated Virus for Enhanced Glial Gene DeliveryMolecular Therapy, 2009
- Generation of Novel AAV Variants by Directed Evolution for Improved CFTR Delivery to Human Ciliated Airway EpitheliumMolecular Therapy, 2009
- Directed evolution of adeno-associated virus for glioma cell transductionJournal of Neuro-Oncology, 2009
- Directed evolution of adeno-associated virus to an infectious respiratory virusProceedings of the National Academy of Sciences, 2009
- A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selectionProceedings of the National Academy of Sciences, 2009
- Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytesNature Biotechnology, 2008
- In Vitro and In Vivo Gene Therapy Vector Evolution via Multispecies Interbreeding and Retargeting of Adeno-Associated VirusesJournal of Virology, 2008
- Efficient Whole-body Transduction with Trans-splicing Adeno-associated Viral VectorsMolecular Therapy, 2007
- Heparan Sulfate Proteoglycan Binding Properties of Adeno-Associated Virus Retargeting Mutants and Consequences for Their In Vivo TropismJournal of Virology, 2006
- Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8Molecular Therapy, 2006